macrocyclic compounds

Preferred Label : macrocyclic compounds;

MeSH definition : Cyclic compounds with a ring size of approximately 1-4 dozen atoms.;

MeSH synonym : compounds, macrocycle; compounds, macrocyclic; macrocycle compounds;

MeSH hyponym : torands; spherands;

MeSH annotation : general or unspecified; prefer specific group or specific compound;

Wikipedia link : https://en.wikipedia.org/wiki/Macrocyclic compounds;

Is substance : O;

Details

Origin ID

D047028;

UMLS CUI

C1449665;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- macrocyclic compounds [MeSH concept]
- spherands [MeSH concept]
- torands [MeSH concept]
Related MeSH Supplementary Concept(s)
- (15)pyN5 [MeSH Supplementary Concept]
- (3R)-methylazacyclodecane [MeSH Supplementary Concept]
- (R,Z)-5-muscenone [MeSH Supplementary Concept]
- (RSSR)-1,9-dibenzyl-3,7,11,15-tetramesityl-1,9-diaza-3,7,11,15-tetraphosphacyclohexadecane [MeSH Supplementary Concept]
- 1,4,7,10-tetramethyl-1,4,7,10-tetraazacyclododecane [MeSH Supplementary Concept]
- 1,4,8,11-tetramethyl-1,4,8,11-tetraazacyclotetradecane [MeSH Supplementary Concept]
- 10'-bis(acetamido)ethane-bis(1,4,7-tri(carboxymethane)-1,4,7,10-tetraazacyclododecane) [MeSH Supplementary Concept]
- 18-diazo-1,4,7,10,13,16-hexaoxacyclononadeca-17,19-dione [MeSH Supplementary Concept]
- 2,9-dipropyl-3,10-dimethyl-1,4,8,11-tetraaza-5,7-12,14-dibenzocyclotetradeca-1,3,8,10-tetraene [MeSH Supplementary Concept]
- 22-hydroxyhaliclonacyclamine B [MeSH Supplementary Concept]
- 3-methyl-1-cyclopentadecanone [MeSH Supplementary Concept]
- 3-methylcyclopentadecenone [MeSH Supplementary Concept]
- 4-cyclopentadecen-1-one [MeSH Supplementary Concept]
- 4-methylcyclopentadecanone [MeSH Supplementary Concept]
- 4-octasulfophenylpyrazinoporphyrazine [MeSH Supplementary Concept]
- 5-cyclohexadecen-1-one [MeSH Supplementary Concept]
- 7-cycloparaphenylene [MeSH Supplementary Concept]
- 8-cycloparaphenylene [MeSH Supplementary Concept]
- 9'-epi-3beta,3'beta-dimethylxestospongin C [MeSH Supplementary Concept]
- AZD5991 [MeSH Supplementary Concept]
- BILN 2061 [MeSH Supplementary Concept]
- GP205 compound [MeSH Supplementary Concept]
- IDX320 [MeSH Supplementary Concept]
- JNJ-26483327 [MeSH Supplementary Concept]
- Jolkinol D [MeSH Supplementary Concept]
- MK-6325 [MeSH Supplementary Concept]
- N,N'-Bis((6-carboxy-2-pyridyl)methyl)-1,7-diaza-12-crown-4 [MeSH Supplementary Concept]
- PF 1163A [MeSH Supplementary Concept]
- PF 1163B [MeSH Supplementary Concept]
- Py-macrodipa [MeSH Supplementary Concept]
- RapaBlock [MeSH Supplementary Concept]
- ST104P compound [MeSH Supplementary Concept]
- TPX-0131 [MeSH Supplementary Concept]
- Viekira Pak [MeSH Supplementary Concept]
- ambrettolide [MeSH Supplementary Concept]
- amythiamicin A [MeSH Supplementary Concept]
- amythiamicin B [MeSH Supplementary Concept]
- amythiamicin C [MeSH Supplementary Concept]
- amythiamicin D [MeSH Supplementary Concept]
- arenosclerin A [MeSH Supplementary Concept]
- arenosclerin B [MeSH Supplementary Concept]
- arenosclerin C [MeSH Supplementary Concept]
- aspercyclide A [MeSH Supplementary Concept]
- aspercyclide B [MeSH Supplementary Concept]
- aspercyclide C [MeSH Supplementary Concept]
- bambus(6)uril [MeSH Supplementary Concept]
- callyazepin [MeSH Supplementary Concept]
- carboxylatopillar(6)arene [MeSH Supplementary Concept]
- carceplex [MeSH Supplementary Concept]
- chirobiotic T [MeSH Supplementary Concept]
- cucurbit(10)uril [MeSH Supplementary Concept]
- cucurbit(5)uril [MeSH Supplementary Concept]
- cucurbit(6)uril [MeSH Supplementary Concept]
- cucurbit(7)uril [MeSH Supplementary Concept]
- cucurbit(8)uril [MeSH Supplementary Concept]
- cucurbit(n)uril [MeSH Supplementary Concept]
- cyclo(-6)-glucopyranosyl-1-4-glucopyranosyl-1-6-glucopyranosyl-1-4-glucopyranosyl-(1-) [MeSH Supplementary Concept]
- cyclo(-6)-glucpyranosyl-1-3-glucopyranosyl-1-6-glucopyranosyl-1-3-(glucopyranosyl-1-6)-glucopyranosyl-1-4-glucopyranosyl-(1-) [MeSH Supplementary Concept]
- cyclo(-6)-glucpyranosyl-1-3-glucopyranosyl-1-6-glucopyranosyl-1-3-glucopyranosyl-1-4-glucopyranosyl-(1-) [MeSH Supplementary Concept]
- cycloheptadeca-9-en-1-one [MeSH Supplementary Concept]
- cyclohexadec-8-en-1-one [MeSH Supplementary Concept]
- cyclotrehalan [MeSH Supplementary Concept]
- decamethylpressocucurbit(5)uril [MeSH Supplementary Concept]
- dracophane [MeSH Supplementary Concept]
- floresolide B [MeSH Supplementary Concept]
- gamitrinib-triphenylphosphonium [MeSH Supplementary Concept]
- gymnorrhizol [MeSH Supplementary Concept]
- haliclonacyclamine A [MeSH Supplementary Concept]
- haliclonacyclamine B [MeSH Supplementary Concept]
- haliclonacyclamine C [MeSH Supplementary Concept]
- haliclonacyclamine E [MeSH Supplementary Concept]
- haliclonin A [MeSH Supplementary Concept]
- incednam [MeSH Supplementary Concept]
- iron-3,3,6,6,9,9-hexamethyl-3,4,8,9-tetrahydro-1H-1,4,8,11-benzotetraazacyclotridecine-2,5,7,10(6H,11H)-tetraone [MeSH Supplementary Concept]
- isoplagiochin A [MeSH Supplementary Concept]
- isoplagiochin B [MeSH Supplementary Concept]
- lepimectin A3 [MeSH Supplementary Concept]
- lepimectin A4 [MeSH Supplementary Concept]
- lonodelestat [MeSH Supplementary Concept]
- maltepolide [MeSH Supplementary Concept]
- merocyclophane C [MeSH Supplementary Concept]
- merocyclophane D [MeSH Supplementary Concept]
- metacridamide A [MeSH Supplementary Concept]
- metacridamide B [MeSH Supplementary Concept]
- nannocystin A [MeSH Supplementary Concept]
- octaamine 1 [MeSH Supplementary Concept]
- oxacyclododecindione [MeSH Supplementary Concept]
- oxacyclohexadec-12(13)-en-2-one [MeSH Supplementary Concept]
- paecilomycin B [MeSH Supplementary Concept]
- paritaprevir [MeSH Supplementary Concept]
- phelligridimer A [MeSH Supplementary Concept]
- radanamycin [MeSH Supplementary Concept]
- repotrectinib [MeSH Supplementary Concept]
- sofosbuvir velpatasvir voxilaprevir drug combination [MeSH Supplementary Concept]
- sorangiolide B [MeSH Supplementary Concept]
- symbiodinolide [MeSH Supplementary Concept]
- syphonoside [MeSH Supplementary Concept]
- tenvermectin [MeSH Supplementary Concept]
- tetraaza(6.1.6.1)paracyclophane [MeSH Supplementary Concept]
- tetralactam macrocycle [MeSH Supplementary Concept]
- tetramethylcucurbit(6)uril [MeSH Supplementary Concept]
- tonantzitlolone [MeSH Supplementary Concept]
- trans-3,3'-dihydroxy-1,5,1',5'-tetrathiacyclodecane [MeSH Supplementary Concept]
- trianglimine [MeSH Supplementary Concept]
- ulimorelin [MeSH Supplementary Concept]
- unantimycin A [MeSH Supplementary Concept]
- vioprolide A [MeSH Supplementary Concept]
- voxilaprevir [MeSH Supplementary Concept]
- xestospongin A [MeSH Supplementary Concept]
- xestospongin B [MeSH Supplementary Concept]
- xestospongin C [MeSH Supplementary Concept]
- xestospongin D [MeSH Supplementary Concept]
See also
- Bridged-Ring Compounds [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients